One particularly appealing dividend stock right now is Bristol Myers Squibb ( BMY 0.10%). It yields 5.4%, which is an ...

Fintel reports that on December 4, 2025, Scotiabank maintained coverage of Bristol-Myers Squibb (NYSE:BMY) with a Sector ...

Bristol Myers Squibb has struggled over the past few years due to patent cliffs. And to make matters worse, it will soon face ...

Bayer repor⁠t​ed positive Phase‌ 3 result⁠s for its FXIa inhi‍bitor as​undexian, h‌itting key efficacy an‍d safety targets ...

Pfizer(NYSE: PFE) and Bristol Myers Squibb(NYSE: BMY) are two of the largest and most respected pharmaceutical companies in ...

Most of the dividend increases announced in the last two weeks of November were in the low-to-mid single-digit percentages.

Bristol Myers Squibb BMY and Gilead Sciences, Inc. GILD are leading biotechnology companies with broad, diverse portfolios ...

The Prudent Speculator is an investment newsletter that has been published monthly since 1977. Buckingham and his team run four value-stock portfolios. The flagship Prudent Speculator Portfolio has ...

Pfizer offers value with a strong dividend, Metsera obesity expansion, PADCEV/Keytruda approval, and an oncology pipeline.

Pre-tax profits at the main Irish unit of pharma giant, Bristol Myers Squibb last year declined by 47% to $2.09 billion ...

SoFi Technologies, Inc. ("SoFi" or the "Company") today announced that it has priced its previously announced underwritten public offering of 54,545,454 shares of its common stock at a price of $27.50 ...

Viwoods today announced the official launch of the AiPaper Reader C, a groundbreaking color E-Ink device that integrates artificial intelligence directly into the reading experience. The product was ...